Industry / Egypt
Government Allows Limited Drug Price Rises
January 2008 | Industry NewsEgypt's Ministry of Health and Population has bowed to pressure from manufacturers worried by rising raw material costs and agreed an 8% increase in the price of 265 drugs, representing 3.4% of the pharmaceuticals registered in Egypt. BMI considers the increase to be long overdue - some of the drugs on the list have remained at the same price for more than 10 years despite significant rises in costs of production over the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
